*By Christian Smith* Deputy Attorney General Rod Rosenstein reportedly offered his verbal resignation to White House Chief of Staff John Kelly on Monday but was told to wait for the president. As of Monday evening, he still has a job ー for now. Rosenstein's undetermined fate will have consequences for Robert Mueller's Russia investigation, said Jonna Spilbor, a former prosecutor. "I think it is going to affect the Mueller investigation in a good way for all of those who think that this investigation has been one long run-on sentence that we need to put a period at the end of," Spilbor said Monday in an interview on Cheddar. Several reports suggested Rosenstein would either resign or be fired Monday ー following an explosive piece in The New York Times last week that he had considered secretly taping conversations with the president and discussed soliciting cabinet members to invoke the 25th Amendment, which would start impeachment proceedings. White House Press Secretary Sarah Huckabee Sanders told reporters that Trump will meet with Rosenstein on Thursday after the president's return from the United Nations General Assembly in New York. In the event that Rosenstein is fired, a replacement might re-invigorate the Russia probe, Spilbor said. "The replacement for Rod Rosenstein will say, 'Ok, you've got 30 days,' ー let's pick an arbitrary number ー 'Give me my report because at the end of that 30 days, I'm going to decide if you live or die,'" Spilbor said. The Justice Department appointed former FBI Director Robert Mueller as special counsel on May 17 of last year to lead an investigation into Russian interference in the 2016 U.S. presidential election. Multiple Trump campaign officials have pleaded guilty to charges ranging from bank fraud to obstruction of justice, but no charges related to Russian collusion have been filed ー which is why Spilbor believes the investigation is dragging. "The investigation has been going on far too long and with far too few results. Why do we keep it going?" Spilbor said. For full interview [click here](https://cheddar.com/videos/how-rosensteins-possible-doj-departure-could-impact-the-russia-investigation).

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More